TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
EWTX

Edgewise Therapeutics Inc

Healthcare · Biotechnology

40.00$ -0.7% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Edgewise Therapeutics Inc (EWTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 480 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EWTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
311 340 554 532 511 487 454 613 583 553 519 480
298 327 541 519 499 475 443 603 574 543 510 472
33 86 30 43 45 42 50 43 46 61 33 72
290 318 533 512 493 470 436 594 563 530 500 461
21 21 19 21 22 28 25 24 25 30 25 32
16 17 15 17 19 24 21 21 22 27 23 29
0.9 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
5.3 4.0 4.7 6.8 5.6 5.6 8.8 8.3 6.2 6.0 7.3 4.7
290 319 535 510 489 459 430 589 559 522 493 448
-215 -245 -273 -305 -339 -379 -419 -455 -496 -546 -595 -653
63 65 88 94 94 92 95 105 105 103 107 108

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?